Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jan;6(1):43-7.
doi: 10.5415/apallergy.2016.6.1.43. Epub 2016 Jan 27.

Stevens-Johnson syndrome and toxic epidermal necrolysis in Dr. Hasan Sadikin General Hospital Bandung, Indonesia from 2009-2013

Oki Suwarsa  1 , Wulan Yuwita  1 , Hartati Purbo Dharmadji  1 , Endang Sutedja  1
Affiliations

Stevens-Johnson syndrome and toxic epidermal necrolysis in Dr. Hasan Sadikin General Hospital Bandung, Indonesia from 2009-2013

Oki Suwarsa et al. Asia Pac Allergy. 2016 Jan.

Abstract

Background: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe cutaneous adverse reactions (SCAR) with high mortality and have a significant public health impact because of high mortality and morbidity.

Objective: To describe data the epidemiological features, etiology, and treatment of retrospectively reviewed data of all patients with SJS and TEN.

Methods: Retrospective study was conducted in patients with SJS and TEN treated from January 1, 2009 to December 31, 2013 in Dr. Hasan Sadikin General Hospital Bandung, Indonesia.

Results: A total of 57 patients were enrolled in the study. Thirty-nine cases of SJS (21 males and 18 females), 7 cases of SJS overlapping TEN (4 males and 3 females), and 11 cases of TEN (5 males and 6 females) were reported. All cases of SJS and TEN were caused by drugs, such as paracetamol (16.56%), carbamazepine (7%), amoxicillin (5.73%), ibuprofen (4.46%), rifampicin (3.18%), and trihexyphenidyl (3.18%). All cases were treated systemically with corticosteroid alone (100%). Seven from 57 patients (12,28%) died; 5 cases developed sepsis and 2 cases developed respiratory failure. The mortality rate was 7.69% in SJS, 0% in SJS/TEN overlap, and 36.36% in TEN.

Conclusion: The role of systemic corticosteroids in SJS and TEN are still controversial, but with a prompt and earlier treatment reduces mortality and improves outcomes of SJS and TEN patients.

Keywords: Corticosteroid Treatment; Stevens-Johnson Syndrome; Toxic Epidermal Necrolysis.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1. Age of patients with SJS (A), SJS/TEN overlap (B), and TEN (C). SJS, Stevens-Johnson syndrome; TEN, toxic epidermal necrolysis.
Fig. 2
Fig. 2. Drug etiology of SJS and TEN. SJS, Stevens-Johnson syndrome; TEN, toxic epidermal necrolysis.
Fig. 3
Fig. 3. Liver involvement in SJS and TEN. SJS, Stevens-Johnson syndrome; TEN, toxic epidermal necrolysis.
See this image and copyright information in PMC

References

    1. Chung WH, Hung SI. Genetic markers and danger signals in stevens-johnson syndrome and toxic epidermal necrolysis. Allergol Int. 2010;59:325–332. - PubMed
    1. French LE. Toxic epidermal necrolysis and Stevens Johnson syndrome: our current understanding. Allergol Int. 2006;55:9–16. - PubMed
    1. Valeyrie-Allanore L, Roujeau JC. Epidermal necrolysis (stevens-johnson syndrome and toxic epidermal necrolysis) In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell D, Wolff K, editors. Fitzpatrick's dermatology in general medicine. 8th ed. New York: McGraw Hill; 2012. pp. 439–448.
    1. Yamane Y, Aihara M, Ikezawa Z. Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan from 2000 to 2006. Allergol Int. 2007;56:419–425. - PubMed
    1. Guegan S, Bastuji-Garin S, Poszepczynska-Guigne E, Roujeau JC, Revuz J. Performance of the SCORTEN during the first five days of hospitalization to predict the prognosis of epidermal necrolysis. J Invest Dermatol. 2006;126:272–276. - PubMed